Category Archive: Hybrid nanoparticles

Jan 29

Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo

Categories:

American Cancer Society, Berthiaume Institute for Precision Health, Hybrid nanoparticles, Indiana Clinical Translational Sciences Institute (I-CTSI), multidrug resistance

by

We are excited to publish on our Phage-mimicking nanoparticles efficiently tackling Group A Streptococcus infections in mouse wound infection models in RSC Nanoscale Advances (https://pubs.rsc.org/en/content/articlepdf/2024/NA/D3NA00620D). Thank you to Prof. Frank Castellino, Prof. Victoria Ploplis, and Deborah Donahue of the W.M. Keck Transgene Center for the in vivo studies. Thanks to Prof. Shaun Lee’s lab (Biology) …

Continue reading »

This post has no tag

Nov 28

Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy

Categories:

Berthiaume Institute for Precision Health, Harper Cancer Research Institute, Hybrid nanoparticles, Immunotherapy

by

Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …

Continue reading »

This post has no tag